I ponder sometimes an old sales features & benefits vs cost psychology.
Applying some thinking to Onc:
We know they are working to get Pela to market. The Roche study being the most aggressive.
Who beinifits if Onc gets Pela to market?
Almost 1 million woman/ year being treated for cancer. Almost 1/2 million. Pancreatic cancer patients who will have a much better chance.
Roche employees will have minium a new product to work with. Increased jobs.
Roche will see increase sales & incresed profits.
ONC will need to further ramp up production. Securing jobs for onc employees.
ONC will eee sales & profits.
dritributors & health care professionals will have additional tolols in the fight for cancer.
Thr corporate value of both Onc & Roche would increase.
office leasing companies will feel better. More secure tenancy.
Business lawyers & auditors would see increased security dealing with ONC.
In simple terms many organizations & most importantly people will benifit from Getting Pelareorep to market.
Who benefits of Onc fails?
the short sellers will make some short term gains. That is about it.
Two important words to blanket iver this philosophical journey.
karma & Dahrm